Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Sell
37
VMD Quote, Financials, Valuation and Earnings
Last price:
$8.29
Seasonality move
:
16.23%
Day range:
$8.12 - $8.47
52-week range:
$5.93 - $8.94
Dividend yield:
0%
P/E ratio:
25.05x
P/S ratio:
1.34x
P/B ratio:
2.36x
Volume:
112.8K
Avg. volume:
163.5K
1-year change:
3.63%
Market cap:
$314.8M
Revenue:
$224.3M
EPS (TTM):
$0.33
Analysts' Opinion
-
Consensus RatingViemed Healthcare, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $13.00, Viemed Healthcare, Inc. has an estimated upside of 57.01% from its current price of $8.28.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $11.00 representing 100% downside risk from its current price of $8.28.
Fair Value
-
According to the consensus of 2 analysts, Viemed Healthcare, Inc. has 57.01% upside to fair value with a price target of $13.00 per share.
VMD vs. S&P 500
-
Over the past 5 trading days, Viemed Healthcare, Inc. has underperformed the S&P 500 by -2.82% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Viemed Healthcare, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Viemed Healthcare, Inc. has grown year-over-year revenues for 16 quarters straight. In the most recent quarter Viemed Healthcare, Inc. reported revenues of $71.9M.
Earnings Growth
-
Viemed Healthcare, Inc. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Viemed Healthcare, Inc. reported earnings per share of $0.09.
Enterprise value:
330.3M
EV / Invested capital:
--
Price / LTM sales:
1.34x
EV / EBIT:
17.95x
EV / Revenue:
1.30x
PEG ratio (5yr expected):
0.87x
EV / Free cash flow:
61.33x
Price / Operating cash flow:
63.32x
Enterprise value / EBITDA:
7.21x
Gross Profit (TTM):
$146.1M
Return On Assets:
7.67%
Net Income Margin (TTM):
5.49%
Return On Equity:
10.37%
Return On Invested Capital:
9.63%
Operating Margin:
9.69%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $169.8M | $214.3M | $254.8M | $58M | $71.9M | |
| Gross Profit | $102.4M | $127.6M | $146.1M | $34M | $40.9M | |
| Operating Income | $13.4M | $16.5M | $18.4M | $5.2M | $7M | |
| EBITDA | $33.7M | $41.5M | $45.8M | $11.6M | $14.5M | |
| Diluted EPS | $0.23 | $0.26 | $0.33 | $0.10 | $0.09 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $47.4M | $42.9M | $35.9M | $47.7M | $50M | |
| Total Assets | $115.5M | $119.4M | $149.4M | $169.5M | $202.4M | |
| Current Liabilities | $20.2M | $20.6M | $31.6M | $36.4M | $44.2M | |
| Total Liabilities | $26.1M | $25.5M | $40.6M | $42.7M | $66.9M | |
| Total Equity | $89.4M | $93.9M | $108.8M | $126.8M | $135.5M | |
| Total Debt | $7.6M | $4.8M | $10.7M | $6.5M | $23.5M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $39.6M | $37.4M | $48.5M | $12.7M | $18.4M | |
| Cash From Investing | -$52M | -$29M | -$51.8M | -$5M | -$32.3M | |
| Cash From Financing | $986K | -$7.1M | $3.1M | -$5.2M | $5M | |
| Free Cash Flow | $15.9M | $3.5M | $5.4M | $1.7M | $10.7M | |
VMD
Sector
Market Cap
$314.8M
$24M
Price % of 52-Week High
92.62%
48.29%
Dividend Yield
0%
0%
Shareholder Yield
3.32%
-1.62%
1-Year Price Total Return
3.63%
-22.92%
Beta (5-Year)
1.273
0.500
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$8.37
200-day SMA
Buy
Level
$6.93
Bollinger Bands (100)
Buy
Level
6.55 - 7.63
Chaikin Money Flow
Buy
Level
745.5K
20-day SMA
Buy
Level
$7.86
Relative Strength Index (RSI14)
Buy
Level
61.16
ADX Line
Buy
Level
44.38
Williams %R
Neutral
Level
-41.25
50-day SMA
Buy
Level
$7.49
MACD (12, 26)
Buy
Level
2.25
25-day Aroon Oscillator
Buy
Level
72
On Balance Volume
Neutral
Level
955.3K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (6.6881)
Buy
CA Score
(Annual)
Level (1.6067)
Buy
Beneish M-Score
(Annual)
Level (-2.8712)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-2.1824)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Viemed Healthcare, Inc. engages in the provision of home healthcare solutions. Through its subsidiaries, it supplies home medical equipment which provides post-acute respiratory services. It also offers respiratory disease management and in-home sleep testing and sleep apnea treatment. The company was founded by Casey Hoyt, Max Hoyt, and Michael Moore in 2016 and is headquartered in Lafayette, LA.
Stock Forecast FAQ
In the current month, VMD has received 2 Buy ratings 0 Hold ratings, and 0 Sell ratings. The VMD average analyst price target in the past 3 months is $13.00.
-
Where Will Viemed Healthcare, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Viemed Healthcare, Inc. share price will rise to $13.00 per share over the next 12 months.
-
What Do Analysts Say About Viemed Healthcare, Inc.?
Analysts are divided on their view about Viemed Healthcare, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Viemed Healthcare, Inc. is a Sell and believe this share price will drop from its current level to $11.00.
-
What Is Viemed Healthcare, Inc.'s Price Target?
The price target for Viemed Healthcare, Inc. over the next 1-year time period is forecast to be $13.00 according to 2 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is VMD A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Viemed Healthcare, Inc. is a Buy. 2 of 2 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of VMD?
You can purchase shares of Viemed Healthcare, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Viemed Healthcare, Inc. shares.
-
What Is The Viemed Healthcare, Inc. Share Price Today?
Viemed Healthcare, Inc. was last trading at $8.29 per share. This represents the most recent stock quote for Viemed Healthcare, Inc.. Yesterday, Viemed Healthcare, Inc. closed at $8.28 per share.
-
How To Buy Viemed Healthcare, Inc. Stock Online?
In order to purchase Viemed Healthcare, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get VMD Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
VMD
Sector
P/E ratio
25.05x
23.44x
PEG ratio
0.87x
-0.01x
P/B ratio
2.36x
1.73x
Price / LTM sales
1.34x
1.51x
Growth Metrics
VMD
Sector
Revenue growth
23.98%
3.31%
Earnings growth
-8.83%
10.7%
Revenue (5-year growth)
22.82%
6.28%
Earnings forecast
$0.10
-$0.19
Profitability
VMD
Sector
Profitability FY 2024
$131.7M
$2.6M
Return on invested capital
9.63%
-33.62%
Return on assets
7.67%
-29.74%
Return on equity
10.37%
-39.33%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Mar
11
Estimated Next Earnings Date
Feb
4
Balance Sheet
VMD
Sector
Total cash
$11.1M
$25M
Short term investments
--
$23.9M
Total assets
$177.1M
$71.9M
Long term debt
$23.5M
$2.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Is Sandisk The Next Big Memory Stock?
Computer memory manufacturer Sandisk (NASDAQ:SNDK) has quietly been one of…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
44
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
77
CPS alert for Feb 14
Cooper-Standard Holdings, Inc. [CPS] is up 32.06% over the past day.
Buy
58
TPH alert for Feb 14
Tri Pointe Homes, Inc. [TPH] is up 26.83% over the past day.
Sell
20
IRON alert for Feb 14
Disc Medicine, Inc. [IRON] is down 21.88% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
